Cancer-associated antigens and methods of their identification and use
US7217421B1 · kind B1 · utility
Assignee
Inventors
Key dates
| Filing date | Jul 6, 2000 |
| Grant date | May 15, 2007 |
| Priority date | — |
| Expiry date | Jul 6, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/5156
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel, isolated, tumor-associated antigens, and methods for identifying such antigens in a biological sample, and of screening for the presence of such an antigen in a biological specimen, wherein the tumor antigen identified reacts with serum from a subject treated with a vaccine comprising a cytokine and proliferation-incompetent tumor cells which express the tumor-associated antigen. Also provided are kits for carrying out the methods of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.